New MRD monitoring techniques could be most accurate predictor of relapse in MM patients
What we can learn about treating CLL from research on other cancers
How to avoid tumor lysis syndrome when treating CLL patients with venetoclax
Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
EBMT 2018: Investigating breakthrough therapies for treating AML in adults